Form 4: Astronics Exec Mulato Granted Performance-Based RSUs
Executive Compensation Grant
Astronics Corp. President of Test Systems, James Mulato, was granted 7,675 performance-based Restricted Stock Units, vesting contingent on future EBITDA targets.
Summary
- James Mulato, President of Astronics Test Systems, was granted 7,675 Restricted Stock Units (RSUs) on February 19, 2026.
- These RSUs are performance-based, with vesting dependent on Astronics Corp.'s average annual adjusted EBITDA for the period January 1, 2026, to December 31, 2028.
- The target number of RSUs is reported, with actual vesting potentially ranging from 50% to 150% of the target based on performance.
- Vesting for these specific RSUs is scheduled for February 19, 2029.
- Mulato also holds 27,077.822 shares of common stock and 2,453 shares of Class B stock.
- Existing derivative holdings include various stock options with exercise prices ranging from $9.74 to $35.61 and expiration dates from December 14, 2026, to December 07, 2033.
- Other outstanding performance-based RSUs include 18,550 units (2024-2026 EBITDA, vesting Feb 22, 2027), 11,500 units (2023-2025 EBITDA, vesting Feb 23, 2026), and 17,700 units (2025-2027 EBITDA, vesting Feb 27, 2028).
Sentiment
Score: 7
Explanation: StockSavvy.ai views this as a moderately positive signal, as it indicates continued executive commitment and aligns management incentives with long-term company performance through performance-based equity awards.
Positives
- The grant of performance-based RSUs aligns management's incentives with long-term company performance, specifically adjusted EBITDA growth.
- The potential for vesting between 50% and 150% of target units provides a strong incentive for exceeding performance goals.
Risks
- Vesting of the granted Restricted Stock Units is contingent on achieving specific average annual adjusted EBITDA targets, meaning the actual number of shares received could be lower than the target if performance metrics are not met.
- The value of the vested RSUs and existing options is subject to the future market price of Astronics Corp. common stock.
Future Outlook
The vesting of a significant portion of executive compensation is tied to Astronics Corp.'s future average annual adjusted EBITDA performance over multi-year periods extending through 2028, indicating a focus on long-term profitability and operational efficiency.
Management Comments
- No direct quotes or paraphrased statements from company management are provided in this Form 4 filing, which is typical for this document type.
Industry Context
StockSavvy.ai notes that tying executive compensation, particularly Restricted Stock Units, to performance metrics like adjusted EBITDA is a common practice across industries. This approach aims to align management's financial interests with shareholder value creation by incentivizing operational profitability and efficiency. For a company like Astronics, operating in aerospace and defense, and test systems, such long-term incentives are crucial for retaining talent and driving strategic growth in a capital-intensive and cyclical sector.
Comparison to Industry Standards
- Tying executive RSU vesting to average annual adjusted EBITDA over multi-year periods (e.g., 2023-2025, 2024-2026, 2025-2027, 2026-2028) is a standard practice in the aerospace and defense and specialized electronics manufacturing sectors.
- Companies such as Raytheon Technologies (RTX), Lockheed Martin (LMT), and Teledyne Technologies (TDY) frequently utilize similar performance-based equity awards to incentivize long-term financial performance and strategic objectives.
- The vesting range of 50% to 150% (or 75% to 115% for some grants) of target units is also within typical industry ranges, providing both downside risk and upside potential based on performance relative to established goals.
Stakeholder Impact
- Shareholders: The performance-based vesting of RSUs aligns executive interests with shareholder value creation by incentivizing improved financial performance (EBITDA).
- Employees: The compensation structure for a key executive may influence overall compensation philosophy and morale within the company.
- Management: The executive's compensation is directly tied to the company's future financial performance, providing a strong incentive to achieve strategic goals.
Next Steps
- Astronics Corp. will continue to operate and report financial results, which will determine the vesting percentage of the performance-based Restricted Stock Units.
- The 11,500 RSUs (target) tied to 2023-2025 EBITDA are scheduled to vest on February 23, 2026.
- The 18,550 RSUs (target) tied to 2024-2026 EBITDA are scheduled to vest on February 22, 2027.
- The 17,700 RSUs (target) tied to 2025-2027 EBITDA are scheduled to vest on February 27, 2028.
- The newly granted 7,675 RSUs (target) tied to 2026-2028 EBITDA are scheduled to vest on February 19, 2029.
Key Dates
| Date | Description |
|---|---|
| 12/14/2017 | Date exercisable for options with $31.76 exercise price, expiring 12/14/2026. |
| 12/12/2018 | Date exercisable for options with $35.61 exercise price, expiring 12/12/2027. |
| 12/13/2019 | Date exercisable for options with $31.57 exercise price, expiring 12/13/2028. |
| 12/09/2020 | Date exercisable for options with $30.04 exercise price, expiring 12/09/2029. |
| 01/22/2022 | Date exercisable for options with $14.45 exercise price, expiring 01/22/2031. |
| 12/09/2022 | Date exercisable for options with $11.13 exercise price, expiring 12/09/2031. |
| 01/01/2023 | Start of performance period for 11,500 RSUs (target) vesting on Feb 23, 2026. |
| 12/16/2023 | Date exercisable for options with $9.74 exercise price, expiring 12/16/2032. |
| 01/01/2024 | Start of performance period for 18,550 RSUs (target) vesting on Feb 22, 2027. |
| 12/07/2024 | Date exercisable for options with $15.15 exercise price, expiring 12/07/2033. |
| 01/01/2025 | Start of performance period for 17,700 RSUs (target) vesting on Feb 27, 2028. |
| 12/31/2025 | End of performance period for 11,500 RSUs (target) vesting on Feb 23, 2026. |
| 02/19/2026 | Grant date of 7,675 Restricted Stock Units to James Mulato. |
| 02/23/2026 | Signature date of the Form 4 filing. |
| 02/23/2026 | Vesting date for 11,500 Restricted Stock Units (target) tied to 2023-2025 EBITDA. |
| 01/01/2026 | Start of performance period for 7,675 RSUs (target) vesting on Feb 19, 2029. |
| 12/14/2026 | Expiration date for options with $31.76 exercise price. |
| 12/31/2026 | End of performance period for 18,550 RSUs (target) vesting on Feb 22, 2027. |
| 02/22/2027 | Vesting date for 18,550 Restricted Stock Units (target) tied to 2024-2026 EBITDA. |
| 12/12/2027 | Expiration date for options with $35.61 exercise price. |
| 12/31/2027 | End of performance period for 17,700 RSUs (target) vesting on Feb 27, 2028. |
| 02/27/2028 | Vesting date for 17,700 Restricted Stock Units (target) tied to 2025-2027 EBITDA. |
| 12/13/2028 | Expiration date for options with $31.57 exercise price. |
| 12/31/2028 | End of performance period for 7,675 RSUs (target) vesting on Feb 19, 2029. |
| 02/19/2029 | Vesting date for 7,675 Restricted Stock Units (target) tied to 2026-2028 EBITDA. |
| 12/09/2029 | Expiration date for options with $30.04 exercise price. |
| 01/22/2031 | Expiration date for options with $14.45 exercise price. |
| 12/09/2031 | Expiration date for options with $11.13 exercise price. |
| 12/16/2032 | Expiration date for options with $9.74 exercise price. |
| 12/07/2033 | Expiration date for options with $15.15 exercise price. |
Recommendation
holdThis Form 4 filing primarily details a routine executive compensation grant of performance-based Restricted Stock Units. While it signals continued executive alignment with long-term company performance, it does not provide new fundamental information about the company's operational or financial health that would warrant a change in investment recommendation. Investors should continue to hold based on broader company fundamentals and market conditions.
Keywords
Astronics Corp, ATRO, Form 4, Restricted Stock Units, RSU, Executive Compensation, Insider Ownership, EBITDA, Performance-Based Compensation, Stock Options
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.